Flumazenil, a Benzodiazepine Receptor Anatagonist, in the Reversal of Conscious Sedation following Gastroscopy. A Placebo Controlled, Dose Finding Study
Tim double-blind, placebo controlled, study assessed the efficacy and safety of flumazenil, a benzodiazepine antagonist, in reversing diazepam-induced sedation in 60 patients undergoing endoscopy. Patients were randomly assigned to one of six treatment groups (placebo, 5, 10, 15, 20 or 25 μg/kg flum...
Main Authors: | Lloyd Sutherland, Noel Hershfield, Eldon Shaffer, Lorne Price, Deanne Dean, Margaret Light |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1991-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1991/971681 |
Similar Items
-
Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification
by: Anna Benini, et al.
Published: (2021-03-01) -
Flumazenil in treatment benzodiazepine withdrawal syndrome: Case report
by: Ramah Aleksandar J., et al.
Published: (2015-01-01) -
Benzodiazepines for conscious sedation in paediatric dental patients
by: Wilson, Katherine
Published: (2005) -
The use of flumazenil for benzodiazepine associated respiratory depression in postanesthesia recovery: risks and outcomes
by: Troy G. Seelhammer, et al.
Published: (2018-07-01) -
Antiulcer activity of the calcium anatagonist propyl-methylenedioxyindene /
by: Wong, Wai-shiu Fred
Published: (1990)